Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Viminol

From Wikipedia, the free encyclopedia
Opioid analgesic medicine
Pharmaceutical compound
Viminol
Clinical data
Trade namesDividol
Other namesDividol, viminolo, diviminol
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
Identifiers
  • 1-[1-[(2-Chlorophenyl)methyl]pyrrol-2-yl]-2-[di(butan-2-yl)amino]ethanol
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.040.301Edit this at Wikidata
Chemical and physical data
FormulaC21H31ClN2O
Molar mass362.94 g·mol−1
3D model (JSmol)
  • CCC(C)N(C(C)CC)CC(O)C1=CC=CN1CC2=CC=CC=C2Cl
  • InChI=1S/C21H31ClN2O/c1-5-16(3)24(17(4)6-2)15-21(25)20-12-9-13-23(20)14-18-10-7-8-11-19(18)22/h7-13,16-17,21,25H,5-6,14-15H2,1-4H3 ☒N
  • Key:ZILPIBYANAFGMS-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Viminol (marketed under thebrandnameDividol) is anopioidanalgesic developed by a team at the drug companyZambon in the 1960s.[2] Viminol is based on the α-pyrryl-2-aminoethanol structure, unlike any other class of opioids.[3][4]

Viminol has bothantitussive (cough suppressing) andanalgesic (pain reducing) effects. Viminol has additional effects similar to other opioids includingsedation andeuphoria.[citation needed] It has six differentstereoisomers which have varying properties. Four are inactive, but the 1S-(R,R)-disecbutyl isomer is aμ-opioid full agonist around 5.5 times more potent thanmorphine and the 1S-(S,S)-disecbutyl isomer is anantagonist.[5][6] Since viminol is supplied as aracemic mixture of isomers, the overall effect is a mixedagonist–antagonist profile similar to that of opioids such aspentazocine, although with somewhat fewer side effects.[7]

Side effects

[edit]

Side effects are similar to other opioids, and can include:[medical citation needed]

However, since viminol is supplied as a racemic mixture of agonist and antagonist isomers, theabuse potential and respiratory depression tends to be less than that of μ-opioid full agonist drugs.[medical citation needed]

Drug dependence may occur.[8]

Related compounds

[edit]

Later work showed that replacing the chlorine atom with a fluorine atom (2F-Viminol) or with atrifluoromethyl group produced a compound with twice the potency and half the acute toxicity.[9] A later team at Zambon found that one isomer of apyrrolidoneanalog is 318 times as potent as morphine in its analgesic activity in animal studies.[10] A number of related compounds were also found to be active, allowing aQSAR model to be constructed.

Trifluoromethyl analog
Fluoro analog "2F-Viminol"
Pyrrolidone analog,Z4349[11]

References

[edit]
  1. ^Anvisa (2024-05-28)."RDC Nº 877 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 877 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União.Archived from the original on 2024-09-25. Retrieved2024-09-25.
  2. ^US 3539589, Teotino UM, Bella DD, "1-(α-Pyrryl)-2-amino Ethanols", issued 10 November 1970, assigned to Whitefin Holding SA 
  3. ^Contri AM (April 1981). "[Chromatographic separation of diastereoisomers of aminoalcohol salts and their densitometric determination]".Il Farmaco; Edizione Pratica (in Italian).36 (4):215–22.PMID 6894429.
  4. ^Neto JM, Murad JE, Monteiro SS (December 1977). "Psychopharmacological properties of the viminol-p-hydroxybenzoate".Revista Brasileira de Pesquisas Médicas e Biológicas.10 (6):361–8.PMID 609773.
  5. ^US 3857857, Della D, Bella CV, Monza DC, Tiotino UM, "Stereoisomers of 1(1'(-O-Chlorobenzyl)-2'-Pyrryl)-2-Disec.Butylamino-Ethanol", issued 31 December 1974, assigned to Whitefin Holding SA 
  6. ^Shook JE, Kallman MJ, Dewey WL (January 1984). "The discriminative stimulus properties of the R2 isomer of viminol".Pharmacology, Biochemistry, and Behavior.20 (1):59–62.doi:10.1016/0091-3057(84)90101-1.PMID 6546450.S2CID 11418389.
  7. ^Cinelli M, Costa V, Ventresca GP, Lodola E (May 1986). "Viminol R2 analgesic activity in patients with postoperative pain: comparison with pentazocine".International Journal of Clinical Pharmacology, Therapy, and Toxicology.24 (5):232–5.PMID 3525423.
  8. ^Turkiewicz G, Baltieri DA (2009). "Dependence on Viminol".Journal of Substance Use.12 (4):301–305.doi:10.1080/14659890701237124.S2CID 71184621.
  9. ^US 4148907, Conti F, "Stereoisomers of 1-(1'benzyl-2'pyrryl)-2-di-sec.-butylaminoethanol and pharmaceutical compositions comprising same", issued 10 April 1979, assigned to Etablissement Viridis 
  10. ^US 4960788, Carenzi A, Chiarino D, Bella DD, Grancini GC, Veneziani C, "Pyrrolidone-2 compounds and their use for central analgesic activity", issued 2 October 1990, assigned to Zambon Group S.P.A. 
  11. ^Napoletano M, Fraire C, Grancini G, Mosotto C, Ricciardi S, Zambon C, et al. (1995). "Stereoselective synthesis and evaluation of all stereoisomers of Z4349, a novel and selective μ-opioid analgesic".Bioorganic & Medicinal Chemistry Letters.6 (5):589–592.doi:10.1016/0960-894X(95)00077-7.
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Viminol&oldid=1288098586"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp